LEE KENNETH B JR 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Feb 2, 2023
Insider Transaction Report
Form 4
LEE KENNETH B JR
Director
Transactions
- Exercise/Conversion
Automatic Stock Option Grant
2023-01-31−15,000→ 0 totalExercise: $1.71From: 2013-06-30Exp: 2023-05-31→ Common Stock (15,000 underlying) - Exercise/Conversion
Common Stock
2023-01-31$1.71/sh+15,000$25,650→ 52,118 total
Footnotes (1)
- [F1]The reporting person engaged in a non-market, cash exercise and hold transaction with respect to these stock options and the underlying shares. The options were originally granted to the reporting person on May 31, 2013 and would have expired on May 31, 2023. No sales of the issuer's common stock have occurred as part of this transaction.